Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists
There is no published human cycling RCT, so these durations are research-planning conventions rather than clinically validated regimens
The extent to which a once-weekly, continuously present amylin analogue reproduces these meal-linked effects as opposed to producing a tonic, non-pulsatile signal quite unlike physiological amylin is a genuinely open question, discussed further in our review of how cagrilintide affects gastric emptying and postprandial metabolism
Splitting each weekly dose into Monday/Thursday injections reduces peak concentration by ~28%, which may explain reports of reduced nausea
The association between rate of initial weight loss and long-term success in obesity treatment: does slow and steady win the race
The hypothesized anti-inflammatory properties of these medications represent a theoretically attractive mechanism for lipedema management, given the inflammatory component of the condition